https://doi.org/10.5812/hepatmon.5945

Recent Advances in Radiofrequency Ablation for the Management of Hepatocellular Carcinoma

authors:

avatar Takashi Himoto 1 , * , avatar Kazutaka Kurokohchi 2 , avatar Seishiro Watanabe 3 , avatar Tsutomu Masaki 2

Department of Integrated Medicine, thimoto@med.kagawa-u.ac.jp, Japan
Department of Gastroenterology and Neurology, School of Medicine, Kagawa University, Japan
Department of Internal Medicine, Kagawa Prefectural Central Hospital, Japan
Hepatitis Monthly: Vol.12, issue 10; 5945
published online: October 10, 2012
article type: Review Article
received: July 31, 2011
accepted: January 9, 2012

How To Cite Himoto T, Kurokohchi K, Watanabe S, Masaki T. Recent Advances in Radiofrequency Ablation for the Management of Hepatocellular Carcinoma. Hepat Mon. 2012;12(10):5945. https://doi.org/10.5812/hepatmon.5945.

Abstract

Contexts:

Hepatocellular carcinoma (HCC) is one of the most common malignant diseases in the world. Because less than 20% of patients with HCC are resectable, various types of non-surgical treatment have been developed.

Evidence Acquisition:

At present, radiofrequency ablation (RFA) is accepted as the standard local treatment for patients with HCC because of its superior local control and overall survival compared to other local treatments.

Results:

New devices for RFA and combination treatments of RFA with other procedures have been developed to improve anti-tumoral effects.

Conclusions:

This review mainly focuses on the status of RFA in the management of HCC and recent advances in RFA treatment technology.

Full Text

Full text is available in PDF